Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Vodobatinib

Generic Name: Vodobatinib

Drug Type: Small Molecule

Chemical Formula: C_₂₇H_₂₀ClN_₃O_₂

CAS Number: 1388803-90-4

Unique Ingredient Identifier: N8Q12KU2SW

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706

Phase 2

Terminated

Posted: 2018/08/31

Sponsor:Sun Pharma Advanced ...

ID:NCT03655236

To Evaluate the Safety, Tolerability and Pharmacokinetics of K0706 in Plasma and Cerebrospinal Fluid in Healthy Volunteers

Phase 1

Completed

Posted: 2018/02/26

Sponsor:Sun Pharma Advanced ...

ID:NCT03445338

Bioavailability Study of K0706 in Healthy Subjects

Phase 1

Completed

Posted: 2017/10/20

Sponsor:Sun Pharma Advanced ...

ID:NCT03316820

Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease

Phase 1

Completed

Posted: 2016/11/21

Sponsor:Sun Pharma Advanced ...

ID:NCT02970019

Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies

Phase 1

Active, not recruiting

Posted: 2015/12/14

Sponsor:Sun Pharma Advanced ...

ID:NCT02629692

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy